Monitoring heart failure with brain natriuretic peptide

B. Sela*

*Corresponding author for this work

Research output: Contribution to journalEditorial

1 Scopus citations


Brain natriuretic peptide (BNP), is a 32 amino acid containing cardiac hormone released from the ventricles due to increased filling pressure and left ventricle wall stretch. For over a decade since its discovery, information is mounting to suggest its superiority over the other natriureic peptide, ANP, as a reliable measure of left ventricular systolic dysfunction. Measurement of BNP concentration in blood emerges as a sensitive and specific test for the identification of patients with congestive heart failure in the urgent-care setting. It is a potent, cost-effective addition to the diagnostic armamentarium and helps in the titration of following therapy and prognosis evaluation.

Original languageEnglish
Pages (from-to)25-31+78
Issue number1
StatePublished - Jan 2003


  • Atrial natriuretic peptide
  • Brain natriuretic peptide
  • Congestive heart failure
  • Dyspnea
  • Left ventricle ejection fraction


Dive into the research topics of 'Monitoring heart failure with brain natriuretic peptide'. Together they form a unique fingerprint.

Cite this